A patient developed bacteremia with CDC group M-6, a Moraxella-like bacterium, after a complicated heart catheterization. He was treated with tobramycin and ampicillin. The aortic valve was later replaced and did not show any signs of infection. The slow growth of M-6 can delay diagnosis and give misleading antibiotic susceptibility results. Penicillin is not always active against this organism.
The bacteria recovered from this patient resemble CDC group M-6 previously described by Tatum and co-workers (5). There are some unexplained discrepancies in recent reports of M-6. Initially, 1 of 33 strains (3%) was susceptible to penicillin (1) . Subsequently, penicillin susceptibility was reported for 32 of 40 strains (88%) (2) .
The initial choice of therapy for group M-6 must take into account the variable susceptibility to penicillin. Slowgrowing organisms show unreliable reactions to antibiotics in liquid media. These reactions occur in tests for MICs and serum bactericidal levels (7) of antibiotics. The blood agar disk diffusion method may be more reliable than the MIC.
Routine heart catheterization usually does not require prophylaxis (3) . Since this patient did not have any bacteriologic proof of endocarditis at surgery, only catheterization could be implicated in his bacteremia.
